VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE
Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM
Venus Remedies Limited VENUSREM listed on NSE and deals in PharmaceuticalsAnnouncements and dividends declared by Venus Remedies Limited VENUSREM
Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
​​ Saransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our global expansion strategy. We are looking forward to introducing the entire range of our oncology products in Uk
Announcement as on 18 March 2024
Company Announcement
Venus Remedies Limited has informed the Exchange regarding 'Venus Remedies Receives Marketing Authorizations for Oncology Drugs in Ukraine (Asia CIS).'.
Announcement as on 11 March 2024
Venus Remedies secures GMP approval from UNICEF
Venus Remedies announced that it has secured good manufacturing practices (GMP) approval from the United Nations Children's Fund (UNICEF) to supply Cephalosporin antibiotics for treating infections.
Announcement as on 11 March 2024
Company Announcement
Venus Remedies Limited has informed the Exchange regarding a press release dated March 06, 2024, titled "Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme".
Announcement as on 06 March 2024
Company Announcement
Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication
Announcement as on 16 February 2024
Announcements by Venus Remedies Limited first page | Next page | Prev page |
VENUSREM Venus Remedies Limited current price & indicator signals
Recent prices of VENUSREM Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 01 Mon Dec 2025 | 727.05 | 665.30 to 748.85 | 5.19% | 0.73 times |
| 28 Fri Nov 2025 | 691.15 | 685.85 to 724.90 | -3.92% | 0.33 times |
| 27 Thu Nov 2025 | 719.35 | 688.00 to 758.00 | 3.13% | 1.2 times |
| 26 Wed Nov 2025 | 697.50 | 657.40 to 699.00 | 2.98% | 0.45 times |
| 25 Tue Nov 2025 | 677.30 | 647.35 to 725.00 | -5.52% | 0.67 times |
| 24 Mon Nov 2025 | 716.90 | 696.15 to 728.95 | 2.28% | 0.73 times |
| 21 Fri Nov 2025 | 700.95 | 680.10 to 725.00 | 1.72% | 1.22 times |
| 20 Thu Nov 2025 | 689.10 | 656.35 to 707.05 | 6.86% | 1.91 times |
| 19 Wed Nov 2025 | 644.85 | 554.05 to 665.85 | 16.21% | 3.05 times |
| 18 Tue Nov 2025 | 554.90 | 550.00 to 569.80 | 0.02% | 0.2 times |
| 17 Mon Nov 2025 | 554.80 | 552.00 to 579.45 | -2.98% | 0.22 times |
| 14 Fri Nov 2025 | 571.85 | 557.50 to 576.00 | 1.46% | 0.29 times |
Videos related to: VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


